Myoviridae phage PDX kills enteroaggregative Escherichia coli without human microbiome dysbiosis

摘要

Bacteriophage therapy can be developed to target emerging diarrhoeal pathogens, but doing so in the absence of microbiome disruption, which occurs with antibiotic treatment, has not been established.